Key result
Low-volume surgical myectomy poses real-world efficacy and safety challenges in obstructive hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Observational analysis shows low-volume surgical myectomy benefits symptom relief in patients, suggesting its role in treatment.
Journal Article The dilemma of 'real-world' (low-volume) surgical myectomy for symptomatic obstructive hypertrophic cardiomyopathy Get access Barry J Maron, Barry J Maron Lahey Hospital and Medical Center, Hypertrophic Cardiomyopathy Center, Burlington, MA 01805, USA Corresponding author. Tel: +1 612 863 3996, Email: [email protected] Search for other works by this author on: Oxford Academic PubMed Google Scholar Ethan J Rowin, Ethan J Rowin Lahey Hospital and Medical Center, Hypertrophic Cardiomyopathy Center, Burlington, MA 01805, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Martin S Maron Martin S Maron Lahey Hospital and Medical Center, Hypertrophic Cardiomyopathy Center, Burlington, MA 01805, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar European Heart Journal, ehaf561, https://doi.org/10.1093/eurheartj/ehaf561 Published: 15 September 2025
No takes yet. Share an insight, caveat, or question.
Maron et al. (2025) conducted an editorial in symptomatic obstructive hypertrophic cardiomyopathy. surgical myectomy was evaluated. This article discusses the dilemma of 'real-world' (low-volume) surgical myectomy for symptomatic obstructive hypertrophic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: